⏱ 1 min read
A marijuana prohibition group and a drug testing trade organization have filed a lawsuit against the Justice Department and the Drug Enforcement Administration, challenging the agencies’ order to reschedule state-authorized medical cannabis products from Schedule I to Schedule III of the federal Controlled Substances Act. The petition for review, filed in the US District Court of Appeals for the District of Columbia by SAM Inc. and the National Drug and Alcohol Screening Association, argues that…
Explore all articles: Uncategorized







